Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Pathologic Complete Response × toripalimab × 1 year × Clear all

Sponsor

Conditions

Triple Negative Breast Neoplasms 12 Nasopharyngeal Carcinoma 10 Carcinoma, Non-Small-Cell Lung 7 Neoplasms 6 Esophageal Squamous Cell Carcinoma 6 Breast Neoplasms 6 Squamous Cell Carcinoma of Head and Neck 5 Colorectal Neoplasms 5 Carcinoma, Renal Cell 5 Advanced Solid Tumor 5 Uterine Cervical Neoplasms 3 Small Cell Lung Carcinoma 3 Recurrence 3 Head and Neck Neoplasms 3 Carcinoma, Transitional Cell 3 Carcinoma, Hepatocellular 3 Stomach Neoplasms 2 Solid Tumor 2 Pancreatic Neoplasms 2 Oropharyngeal Neoplasms 2 Neoplasm Metastasis 2 NSCLC 2 Liver Neoplasms 2 Esophageal Neoplasms 2 Carcinoma, Squamous Cell 2 Urinary Bladder Neoplasms 1 Turcot syndrome 1 Stage IB-IIIB NSCLC 1 Solid Tumor, Adult 1 Solid Cancer 1

Interventions

Carboplatin 4 pembrolizumab 3 Paclitaxel 3 Capecitabine 3 Azacitidine 3 venetoclax 2 pertuzumab 2 olaparib 2 durvalumab 2 Trastuzumab 2 Standard of Care 2 Oxaliplatin 2 Observation 2 Irinotecan 2 Immunotherapy 2 Immune Checkpoint Inhibitors 2 Chemoradiotherapy 2 zanidatamab 1 veliparib 1 tucatinib 1 trilaciclib 1 trebananib 1 trastuzumab duocarmazine 1 tislelizumab 1 tegafur-gimeracil-oteracil 1 taxane 1 talazoparib 1 tagraxofusp 1 sarilumab 1 sargramostim 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡